Specright is the first cloud-based, patented platform for Specification Data Management - the digital backbone that captures the DNA-level data of products, packaging, formulas, and bills of materials in a single source of truth. Founded in 2014 by packaging veteran Matthew Wright, it helps the world's largest brands and challenger startups cut costs, accelerate innovation, and reduce waste by replacing scattered spreadsheets with connected, auditable specification data. The platform now hosts more than 5 million products and is layering AI across formulation and spec-first PLM workflows.
Quantum Boost is a London-based deep-tech startup building an AI formulation assistant for the chemicals and materials industry. Its platform uses Bayesian optimization and machine learning to help R&D scientists design smarter experiments, cut the number of lab trials needed to hit a target, and surface insights from existing experimental data. The company claims its approach reaches formulation targets roughly 2-5x faster than traditional Design of Experiments (DoE), and serves teams working on inks, paints and coatings, pharmaceuticals, and specialty chemicals.
Albert Invent builds an AI-native operating system for chemists and materials scientists, unifying electronic lab notebooks, LIMS, regulatory compliance and predictive AI into one cloud platform that aims to compress decades-long R&D cycles into weeks.
Nick Talken is the Co-Founder and CEO of Albert Invent, an Oakland-based AI platform that is transforming how chemists and materials scientists do research and development. A chemical engineer by training who learned to code, Talken spent years inside Henkel's global R&D organization before spinning out Albert Invent in 2022 with a team of co-founders who built the product from within. The company's platform - used by over 3,000 scientists across 142+ labs in 30+ countries at companies like Kenvue, Henkel, and Chemours - has raised over $52 million from top-tier investors including Coatue, Index Ventures, TCV, and J.P. Morgan Private Capital.
Alchemy Cloud is an enterprise SaaS company building an AI-powered Applied Sciences Platform - a unified Electronic Lab Notebook, LIMS, and PLM system that helps specialty chemicals, materials, and consumer-goods R&D teams formulate, test, and commercialize products faster.
Chris Emerson, PhD, is the Founder, Chief Scientist, and CEO of LEVEL, California's #1 cannabis tablet brand. A US Navy veteran and Chinese interpreter turned small-molecule chemist, he abandoned a Stanford postdoc in 2012 to spend four months living in a tent on a Mendocino cannabis farm - and emerged with a founding thesis that would reshape how the industry thinks about getting high. Instead of chasing THC percentages, he built LEVEL around effects-driven cannabinoid formulations using precise ratios of acidic, neutral, and degradative compounds the plant alone can't deliver. Two US patents, multiple peer-reviewed publications, and an IRB-approved clinical trial later, LEVEL is the top-selling cannabis tablet brand in California, now operating in seven states.
Sasha Novakovich is the Founder and CEO of Alchemy Cloud, a San Francisco-based enterprise SaaS company bringing AI-powered lab management and product development software to the specialty chemicals and applied sciences industries. Born in Russia and raised in Los Angeles after immigrating at age five, she built her first company in 1999, sold it to CNET, spent years as an angel investor backing female-led startups, and then spotted a glaring gap - brilliant chemists stuck doing brilliantly manual work with spreadsheets. Alchemy is her answer: a connected lab platform that merges ELN, LIMS, DOE, and AI into one system to help companies like those in beauty, food, building materials, and industrial chemicals bring better products to market faster.